Clal Insurance’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Clal Insurance’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-67,254	Closed	-$140K	–	130
2019 Q4	$140K	Buy	+67,254	New	+$3.32M	0.15%	77
2018 Q1	–	Sell	-2,250,000	Closed	-$116M	–	78
2017 Q4	$116M	Hold	2,250,000	–	–	3.05%	12
2017 Q3	$117M	Sell	2,250,000 -426,846	-16%	-$21.9M	2.83%	9
2017 Q2	$139M	Sell	2,676,846 -38,271	-1%	-$1.93M	2.76%	8
2017 Q1	$137M	Buy	2,715,117 +1,350,117	+99%	+$66.8M	2.79%	8
2016 Q4	$64.3M	Buy	+1,365,000	New	+$64.8M	1.2%	15

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance's IHE Position: Q1 2020 in Review

Clal Insurance sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2020, closing a stake of 67,254 shares — an estimated $140K sold.

Clal Insurance first reported a position in IHE in Q4 2016 and held it in 6 quarters. The position peaked at $139M in Q2 2017. 92 funds tracked by Wall St. Rank hold IHE as of Q1 2020.

Clal Insurance reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
Clal Insurance sold 67,254 iShares US Pharmaceuticals ETF shares in Q1 2020, an estimated $140K.
Clal Insurance first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 6 quarters.
Clal Insurance's iShares US Pharmaceuticals ETF position peaked at $139M in Q2 2017.
92 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2020.

Based on Clal Insurance's 13F filing for Q1 2020, filed 15 May 2020.